Anti-MYH1 monoclonal antibody, clone NZ-43

The three cerebral cavernous malformations (CCMs) genes namely CCM1/KRIT1, CCM2/MGC4607 and CCM3/PDCD10 have been identified for which mutations cause cerebral cavernous malformations. However, the protein products of these genes involved in forming CCM signaling, are still poorly understood imposing an urgent need to understand these genes and their signaling processes in details. So far involvement of CCM3/PDCD10 in the cavernous angioma has been,characterized from biochemical and biophysical analyses. However, there is no comprehensive study illustrating the phylogenetic history and comprehensive genetic variants of CCM3/PDCD10. Herein, we explored the phylogenetic history and genetic variants of CCM3/PDCD10 gene. Synteny analyses revealed that CCM3/PDCD10 gene shared same genomic loci from Drosophila to human and the gene structure of CCM3/PDCD10 is conserved from human to Branchiostoma floridae for about 500 MYs with some changes in sea urchin and in insects. The conserved CCM3/PDCD10 is characterized by presence of indels in the N-terminal dimerization domain. We identified 951 CCM3/PDCD10 variants by analysis of 1092 human genomes with top three variation classes belongs to 84% SNPs, 6.9% insertions and 6.2% deletions. We identified 22 missense mutations in the human CCM3/PDCD10 protein and out of which three mutations are deleterious. We also identified four stop-codon gaining mutations at the positions E34*, E68*, E97* and E140*, respectively. This study is the first comprehensive analysis of the CCM3/PDCD10 gene based on phylogenetic origin and genetic variants. This study corroborates that the evolution of CCM proteins with tubular organization evolvements by endothelial cells. (C) 2014 Elsevier Inc. All rights reserved.

The two Drosophila position-specific (PS) integrins are expressed on complementary sides of sites where different cell layers adhere to each other, such as the attachments of the embryonic muscles to the epidermis. While there is suggestive evidence that the PS integrin-mediated adhesion is via the extracellular matrix, it is also possible that it occurs through the direct interaction of the two integrins, alpha(PS1)beta(PS) and alpha(PS2)beta(PS). To help distinguish between these possibilities a comparison between the phenotypes caused by the absence of the beta(PS) subunit and the absence of one of the PS alpha subunits, alpha(PS2), has been made. Two pieces of evidence are provided that prove that the alpha(PS2) subunit is encoded by the locus inflated (if). Firstly, three new if alleles have been isolated, each of which is associated with a molecular lesion in the alpha(PS2) gene, and each of which results in the complete loss of if activity. Secondly, a 39 kb fragment of genomic DNA that encompasses the alpha(PS2) gene completely rescues if mutations when introduced into the germline by P-element-mediated transformation. A comparison of the null inflated phenotype with that of the locus that encodes the beta PS subunit, myospheroid (mys), reveals that while the PPS subunit is required for the adhesion of the epidermis along the dorsal midline, the alpha(PS2) submit is not. In if mutant embryos, the muscles remain attached to the other cell layers significantly longer than in a mys mutant embryo. This shows that the alpha(PS2)beta(PS) integrin only contributes part of the adhesive activity at the sites of PS integrin adhesion, and rules out a model where PS integrin function occurs solely by the direct interaction of the two PS integrins.